Sage Journals: Discover world-class research

Free access

Review article

First published 2014-12

The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma

Claudia V. Andreu-Vieyra, James R. Berenson

Therapeutic Advances in Hematology

Free access

Research article

First published 2018-9

An Improved and Efficient Synthesis of Panobinostat

Shanwen Chen, Peiming Zhang, Huali Chen [...]

Journal of Chemical Research

Retricted access

Review article

First published 2019-4

Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma

Donald C Moore, Justin R Arnall, R Donald Harvey

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2015-10

Dinutuximab and Panobinostat

Ashley Chasick, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Retricted access

Case report

First published 2020-3

Successful treatment of refractory metastatic neuroblastoma with panobinostat in combination with chemotherapy agents and iodine-131-meta-iodobenzylguanidine therapy

Soheila Zareifar, Nader Shakibazad, Omid Reza Zekavat [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2016-02

Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4 + T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb

Md Saha Jamaluddin, Pei-Wen Hu, Yih Jan [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2018-2

Reply to Commentary: “Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?”

Karine Dubé, Laurie Sylla, Lynda Dee

Journal of Empirical Research on Human Research Ethics

Open access

Research article

First published 2016

LBH589,A Hydroxamic Acid-Derived HDAC Inhibitor,is Neuroprotective in Mouse Models of Huntington’s Disease

Vanita Chopra, Luisa Quinti, Prarthana Khanna [...]

Journal of Huntington's Disease

Retricted access

Research article

First published 2021-6

Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials

Eric P Borrelli, Conor G McGladrigan

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2016-4

Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Emily Ashjian, Kimberly Redic

Journal of Oncology Pharmacy Practice

Search results